INTRODUCTION
Rheumatoid arthritis is the most common inflammatory arthritis affecting 0.5 to 1% of general population worldwide.
1 Several studies have documented increased morbidity and mortality in RA, in a Canadian study it was found that RA patients had a median survival 17 years shorter than expected for general population.
2
RA is a high-grade inflammatory disease with an overlapping cellular and cytokine profile; thus, it has been hypothesized that rheumatoid inflammation is a major cause of the accelerated atherosclerosis observed in this patient population, there is increasing evidence that traditional non
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Modifiable cardiovascular risk factors in Rheumatoid Arthritis modifiable and modifiable cardiovascular risk factors also play an important role in the higher risk of coronary atherosclerosis and coronary heart disease (CHD) events (fatal myocardial infarction, CHD deaths) in patients with RA.
3 Atherosclerosis (AT) was once considered to be a degenerative disease that was an inevitable consequence of aging. However, research in the last three decades has shown that AT is not degenerative or inevitable. It is an autoimmune-inflammatory disease associated with infectious and inflammatory factors characterized by lipoprotein metabolism alteration that leads to immune system activation with the consequent proliferation of smooth muscle cells, narrowing arteries, and atheroma formation. Both humoral and cellular immune mechanisms have been proposed to participate in the onset and progression of AT.
4
Systemic inflammatory response in RA is critical to accelerated atherogenesis operating via accentuation of established and novel risk pathways and long term suppression of systemic inflammatory response should be effective in reducing the risk of coronary heart disease. 5 The rationale of this study was most of Rheumatoid Arthritis are treated by nontraditional ways due to lack of awareness about the disease its course and its aggressiveness and extra articular manifestations which pose a serious threat to health of a patient. This scarcity of knowledge about the disease leads to injudicious use of corticosteroids and non-steroidal anti-inflammatory medicines results into risk of having complications like cardiovascular problems, which sometime leads to early and unexpected deaths.
METHODS
This cross sectional study was conducted in outpatient department of Rheumatology division of Medicine Department at Central Park Medical College Hospital Lahore from July 1, 2016 to January 31, 2017 after the approval of Institutional review board. Written and informed consent were taken from each participant. RA was diagnosed according to 2010 American College of Rheumatology criteria.
Sample size was estimated using openepi sample size calculator by inserting the 80% prevalence of at least one modifiable risk factor in RA patients 3 ,with 5% margin of error and 95% confidence interval n = 246 patient for this study.
All those patients of rheumatoid arthritis who were seropositive for either Rheumatoid factor or Anti citrillinuted peptides or both were included in this study, their demographic data and disease duration number of Disease Modifying anti rheumatoid drugs usage asked in detail.
All those patients who are sero-negative Rheumatoid Arhtirtis, psoriatic arthritis, Systemic Lupus erythematous, scleroderma, osteoarthritis, or any other connective tissue disease, using lipid lowering drugs, or on biological Disease modifying drugs, previous history of Myocardial Infarction, stroke, transient ischemic attack, or coronary revascularization were excluded from the study.
Body Mass Index (weight measured using a beam balance scale and height measured by a stadiometer) was calculated by dividing weight (in kilogram) by square of height (in meters), all those who has BMI score of 30 or more than thirty were labeled as Obese.
Hypertension was assessed by taking Blood pressure(mercury sphygmomanometer) in sitting position after five minutes rest, three times and mean of two last readings was noted and if readings were of >140mmHg systolic or 90mmHg diastolic pressure was taken as hypertension either self-reported diagnosis or any patient who was taking anti-hypertensive. Smoking status was evaluated in detail about the number of years since smoking, number of cigarettes per day and active or Ex-smoker.
Diabetes Mellitus was labeled by measuring Fasting blood glucose level and one who has Fasting blood glucose level of >126 mg /dl was labeled as Diabetes mellitus and patients either self-reported diagnosis or using insulin and/ or oral hypoglycemic drugs.
Serum Cholesterol, HDL (high density lipoprotein),TG(Triglycerides), were measured for every study participant; 5ml of blood sample was drawn by a trained phlebotomist after 14 hours of fasting than blood samples were analyzed on ROCHEIII laboratory. LDL( Low density lipoproteins) was calculated by this Friedewald formula, LDL = TC -HDL -TG/5.0 (mg/dL).
Framingham risk score was calculated for each individual through an online calculator by setting the parameters and categorized into Low (<10%), Moderate (11-19%) , High risk category (>20).
Study participants were asked about the use of Homeopathic Medications currently/past for more than six months, positive history of more than six months use was taken as study parameter. Logistic regression analysis was performed to give the association of Modifiable cardiovascular risk factors and other parameters with duration of RA disease, odds ratio and 95% confidence interval for odds ration also given in the table. All p-values less than 0.05 were considered as significant.
RESULTS
In this study there were 246 participants, males 58 (23.6%) and females 188 (76.4%), with mean age of male group was (50. Table-I) The prevalence of obesity it was found that males 53.4% (n=31) and 46% (n=88) were having BMI> 30 with (p-0.132). Hypertension was present in 50% (n=29) males 33.5% (n=63) females. Diabetes was present in males 24.1% (n=14) females 22.3% (n=42) with (p-0.08). Disease Modifying anti rheumatoid drugs in study participants methotrexate combination was more in use males 37.9% (n=22) and 60.1% (n=113) with (p-0.01). Use of homeopathic medication was males 75.9% (n=44) in females 57.4% (n=108) with (p-value 0.012). (Table-II) Most frequent risk factor found in this study was BMI>30 in 48.4% (n=119), High LDL 43.5% (n=107), moderate to high FRS score 40.2% (n=99), Hypertension 37.4% (n=92), Diabetes Mellitus was present in 22.8% (n=56), while smoking was least frequent risk factors with frequency of 15.9% (n=39). (Fig.1) At least single cardiovascular risk factors was present in 78.48% (n=192) and absent in 21.55% (n=54),while (21.55%) were having at least one risk factors,(15.05%) had two risk factors, (16.67%) had three risk factors, (19.92%) were having four factors, and (4.8%) had five risk factors. (Fig.2) Regression analysis was applied to see the effects of disease duration on these risk factors, it was seen that Rheumatoid Arthritis patients having disease duration of seven or more than seven years had more chances to develop modifiable cardiovascular risk factors. Older patients of Rheumatoid Arthritis with disease duration of more than seven years were four times more likely to have High Framingham risk score, moderate to high LDL and diabetes mellitus with significantly high Odds ratio (p-value <0.05) Table- III. Use of Non Methotrexate Disease Modifying anti rheumatoid drugs was also associated with 4 times more risk to develop these modifiable cardiovascular risk factors as well.
Age, sex, history of homeopathic medications, High BMI> 30, was also associated with 1-3% more chance to develop modifiable cardiovascular risk factor. 
Modifiable cardiovascular risk factors in Rheumatoid Arthritis

DISCUSSION
In patients of rheumatoid arthritis the major cause of mortality is cardiovascular diseases not the RA itself, and the main cause of increased risk of CVD is atherosclerosis. Rheumatoid arthritis increases the cardiovascular mortality by up to 50% compared with general population, interestingly the pattern of cardiovascular diseases is different too, as most of patient suffer silent myocardial infarction and ischemic heart disease and experience sudden death. Traditional cardiovascular risk factors hypertension, Type-2 diabetes, smoking, hyperchloestremia, obesity and physical inactivity contributes to the excessive CVD risk to some extent, it is the high systemic inflammatory burden associated with RA appears to be decisive factor. 6 Despite of recent improvements in treatment the gap between RA patients and general populations in terms of mortality secondary to cardiovascular complications is not decreasing so it is important to control baseline cardiovascular risk. 7 Sharmayne et al in their cross sectional control study found that patients with RA had higher BMI (28.05) than controls (26.25). 
